Xponance’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Sell |
|
|||||
|
2025
Q1 | $660K | Sell |
|
|||||
|
2024
Q4 | $1.3M | Sell |
|
|||||
|
2024
Q3 | $1.43M | Buy |
|
|||||
|
2024
Q2 | $1.45M | Sell |
|
|||||
|
2024
Q1 | $1.94M | Buy |
|
|||||
|
2023
Q4 | $1.59M | Sell |
|
|||||
|
2023
Q3 | $1.45M | Buy |
|
|||||
|
2023
Q2 | $1.48M | Sell |
|
|||||
|
2023
Q1 | $2.39M | Buy |
|
|||||
|
2022
Q4 | $2.58M | Buy |
|
|||||
|
2022
Q3 | $2.13M | Buy |
|
|||||
|
2022
Q2 | $2.09M | Buy |
|
|||||
|
2022
Q1 | $2.35M | Buy |
|
|||||
|
2021
Q4 | $3.07M | Buy |
|
|||||
|
2021
Q3 | $3.03M | Sell |
|
|||||
|
2021
Q2 | $2.78M | Sell |
|
|||||
|
2021
Q1 | $2.83M | Buy |
|
|||||
|
2020
Q4 | $2.42M | Buy |
|
|||||
|
2020
Q3 | $2.19M | Buy |
|
|||||
|
2020
Q2 | $1.56M | Buy |
|